Two-Drug Strategy Targets Evading Prostate Cancers | Science News

Scientists are unlocking a powerful new strategy to tackle aggressive, treatment-resistant prostate cancers that disguise themselves by switching cellular identities. By combining two drugs—one that blocks identity-shifting pathways and another that restores lost glandular traits—researchers have dramatically slowed tumor growth in lab and mouse studies. This breakthrough could soon lead to clinical trials and may even apply to other cancers like lung or pancreatic tumors that undergo similar transformations. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/6b94235560ed9e51